Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

Study Identifier
198782-002
CT.gov Identifier
NCT00651586
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Eye Care - Other
  • Eye Disease
    • Study Drug
  • Gatifloxacin 0.3% ophthalmic solution
  • Ciprofloxacin 0.3% ophthalmic solution
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    8+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinical diagnosis in one eye only of an acute bacterial corneal ulcer (\>1mm)
    Exclusion Criteria:
    * Corneal ulcer that in the opinion of the investigator had to be treated with fortified antibiotics, or multiple antibiotics, or anti-infectives other than study medication

    Protocol Summary

    This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers

    Study Locations

    Location
    Status
    Location
    Galveston, Texas, United States
    Status
    Not applicable
    Location
    Madurai, Tamil Nadu, India
    Status
    Not applicable